| Lloyd Beckwith, PHD | |
|
815 3rd Ave, Chula Vista, CA 91911-1307 | |
| (619) 795-0175 | |
| (619) 795-0115 |
| Full Name | Lloyd Beckwith |
|---|---|
| Gender | Male |
| Speciality | Psychologist - Clinical |
| Location | 815 3rd Ave, Chula Vista, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215003538 | NPI | - | NPPES |
| PSY 9222 | Other | CA | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | PSY 9222 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lloyd Beckwith, PHD 1728 Granada Ave, San Diego, CA 92102-1438 Ph: () - | Lloyd Beckwith, PHD 815 3rd Ave, Chula Vista, CA 91911-1307 Ph: (619) 795-0175 |
News Archive
The brains of people with recurrent depression have a significantly smaller hippocampus - the part of the brain most associated with forming new memories - than healthy individuals, a new global study of nearly 9,000 people reveals.
In Danish volunteers, sunburn was typically associated with female sex, younger age, high risk behaviors like sunbathing, and long hours exposed to the sun, according to an article in the April issue of Archives of Dermatology.
Placement of copper objects in intensive care unit (ICU) hospital rooms reduced the number of healthcare-acquired infections (HAIs) in patients by more than half, according to a new study published in the May issue of Infection Control and Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America, in a special topic issue focused on the role of the environment in infection prevention.
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing its first-in-class, anti-infective Aganocide compounds for the local non-systemic treatment and prevention of antibiotic-resistant infections, today provided an update on its Phase 2 clinical trial for the use of its lead compound, NVC-422, to prevent urinary catheter blockage and encrustation which is often a contributing factor to urinary tract infections in chronically catheterized patients.
› Verified 5 days ago
Dr. Andrew Lowell Cooper, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 815 3rd Ave, Suite 107, Chula Vista, CA 91911 Phone: 619-615-8850 | |
Aurea C Rodriguez, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1180 Third Ave Ste C3, Chula Vista, CA 91911 Phone: 619-691-8164 | |
Abigail Guzman, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1055 Hunte Pkwy, Chula Vista, CA 91914 Phone: 619-292-8343 | |
Alexandria Ann Schmidt, ED.S Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1145 Camino Prado, Chula Vista, CA 91913 Phone: 619-216-6550 | |
Damian Vaquera, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1650 Exploration Falls Dr, Chula Vista, CA 91915 Phone: 619-591-5500 | |
Dr. Carolyn Frances Jacobs, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 625 3rd Ave, Chula Vista, CA 91910 Phone: 619-525-7747 Fax: 619-476-7566 | |
Dr. Don Edward Miller, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 815 3rd Ave, Suite 307, Chula Vista, CA 91911 Phone: 619-422-2458 Fax: 619-422-1905 |